Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial

Open access
Guimarães, Mara C., Guimarães, Tiago M., Hallak, Jaime E., Abrão, João, Machado-de-Sousa, João P. · 2021 · Brazilian Journal of Psychiatry

Abstract

OBJECTIVE: Major depressive disorder (MDD) is related to glutamatergic dysfunction. Antagonists of glutamatergic N-methyl-D-aspartate receptor (NMDAR), such as ketamine, have antidepressant properties. Nitrous oxide (N2O) is also a NMDAR antagonist. Thus, this study aimed to evaluate the effects of augmenting antidepressant treatment with N2O. METHODS: This double blind, placebo-controlled randomized parallel pilot trial was conducted from June 2016 to June 2018 at the Hospital das Clínicas, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Twenty-three subjects with MDD (aged 18 to 65, on antidepressants, with a score > 17 on the 17-item-Hamilton Depression Rating Scale [HAM-D17]) received 50% N2O (n=12; 37.17±13.59 years) or placebo (100% oxygen) (n=11; 37.18±12.77 years) for 60 minutes twice a week for 4 weeks. The primary outcome was changes in HAM-D17 from baseline to week 4. RESULTS: Depressive symptoms improved significantly in the N2O group (N2O: from 22.58±3.83 to 5.92±4.08; placebo: from 22.44±3.54 to 12.89±5.39, p < 0.005). A total of 91.7% and 75% of the N2O group subjects achieved response (≥ 50% reduction in HAM-D17 score) and remission (HAM-D17 < 7), respectively. The predominant adverse effects of N2O treatment were nausea, vomiting, and headache. CONCLUSION: N2O treatment led to a statistically significant reduction in HAM-D17 scores compared to placebo. CLINICAL TRIAL REGISTRATION: Brazilian Register of Clinical Trials, RBR-5rz5ch.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1590/1516-4446-2020-1543

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow diagram describing the trial’s sample recruitment steps and group allocation. HCFMRP-USP = Hospital das Clínicas, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo; HAM-D = Hamilton Depression Rating Scale; N2O = nitrous oxide.
Figure 1 Flow diagram describing the trial’s sample recruitment steps and group allocation. HCFMRP-USP = Hospital das Clínicas, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo; HAM-D = Hamilton Depression Rating Scale; N2O = nitrous oxide.CC BY-NC · PubMed Central
Figure 2 The effects of N2O on depressive symptoms measured with the HAM-D17. Assessment points with significant differences between groups: * session 4 post-inhalation: p = 0.027; † session 7 post-inhalation: p = 0.008; ‡ session 8 pre-inhalation: p = 0.046; § session 8 post-inhalation: p = 0.003. HAM-D17 = 17-item-Hamilton Depression Rating Scale; N2O = nitrous oxide; post = post-inhalation assessment; pre = pre-inhalation assessment.
Figure 2 The effects of N2O on depressive symptoms measured with the HAM-D17. Assessment points with significant differences between groups: * session 4 post-inhalation: p = 0.027; † session 7 post-inhalation: p = 0.008; ‡ session 8 pre-inhalation: p = 0.046; § session 8 post-inhalation: p = 0.003. HAM-D17 = 17-item-Hamilton Depression Rating Scale; N2O = nitrous oxide; post = post-inhalation assessment; pre = pre-inhalation assessment.CC BY-NC · PubMed Central
Figure 3 Time distribution of mean Young Mania Rating Scale (YMRS) score changes at each assessment point. N2O = nitrous oxide.
Figure 3 Time distribution of mean Young Mania Rating Scale (YMRS) score changes at each assessment point. N2O = nitrous oxide.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 47

Metadata

Authors
Guimarães, M. C., Guimarães, T. M., Hallak, J. E., Abrão, J., & Machado-de-Sousa, J. P.
Affiliations
  • Universidade de São Paulo (BR)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (BR)
  • Universidade de São Paulo (USP), Brazil; Instituto Nacional de Ciência e Tecnologia Translacional em Medicina (INCT-TM), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brazil
Corresponding author
Guimarães, Mara C.
Venue
Brazilian Journal of Psychiatry
Published
2021-10
Volume
43
Issue
5
Pages
484-493
ISSN
  • 1516-4446 (ISSN-L)
  • 1809-452X
OpenAlex
W3131166628
Cited by
42
References
36
Citations by year
2026: 3 · 2025: 12 · 2024: 9 · 2023: 8 · 2022: 7 · 2021: 3
FWCI
3.94
Type
journal article
Language
en
Open access
Licence
Locations
  • Brazilian Journal of Psychiatry (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
Keywords
nitrous oxide, major depressive disorder, adjunctive therapy, NMDA receptor antagonists, antidepressant augmentation, glutamatergic dysfunction, ketamine, HAM-D-17, treatment response and remission, adverse effects
MeSH terms
Antidepressive Agents, Brazil, Major Depressive Disorder, Double-Blind Method, Humans, Nitrous Oxide, Pilot Projects, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial. https://app.cochat.ai/papers/10.1590/1516-4446-2020-1543
The paper
Guimarães, M. C., Guimarães, T. M., Hallak, J. E., Abrão, J., & Machado-de-Sousa, J. P. (2021). Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial. Brazilian Journal of Psychiatry. https://doi.org/10.1590/1516-4446-2020-1543

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.